Back to XTX Topco Ltd XTX Topco Ltd

ARQT

14 quarters

Position history for XTX Topco LtdXTX Topco Ltd's holdings in Arcutis Biotherapeutics, Inc.

Yes. XTX Topco holds 45,545 shares of ARQT (Arcutis Biotherapeutics), worth $1.2M, as of its Q2 2026 13F filing. It increased the position by 2,861 shares (+6.7%) from Q1 2026. XTX Topco has held ARQT since Q1 2025, across 6 quarterly 13F filings.

Current Value

$1.2M

Current Shares

45,545

Total Value Change

+$1M

Total Shares Change

+33,323

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
45,545
+6.7%
$1.2M0.0%$26.22
27
2026-Q1
Decreased
42,684
-42.6%
$1M0.0%$23.56
0
2025-Q4
Increased
74,358
+557.9%
$2.2M0.1%$29.04
42
2025-Q3
Decreased
11,303
-69.9%
$213,0620.0%$18.85
0
2025-Q2
Decreased
37,555
-49.0%
$526,5210.0%$14.02
0
2025-Q1
New
73,676
-
$1.2M0.1%$15.64
35
2024-Q4
Exited
0
-100.0%
$00.0%$13.93
0
2024-Q3
Increased
47,728
+30.9%
$443,8700.0%$9.30
30
2024-Q2
Increased
36,466
+241.7%
$339,1340.0%$9.30
38
2024-Q1
Decreased
10,673
-92.7%
$105,7690.0%$9.91
0
2023-Q4
Increased
146,062
+522.6%
$471,7800.1%$3.23
46
2023-Q3
New
23,460
-
$124,5730.0%$5.31
31
2023-Q1
Exited
0
-100.0%
$00.0%$11.00
0
2022-Q4
New
12,222
-
$180,8860.0%$14.80
31

Other major holders of ARQT: BlackRock, Inc., Jennison Associates LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used